J44.9 J18 J45 C34 J84.9 E84
Conditions
Interventions
Group 1: Part 1: After inclusion, patients choose to contribute one or more of the following samples for a single time: nose swab: a sterile swab is inserted 2-3 cm into one nostril, sideway pressure
Sponsors
Pneumologie/Allergologie, Medizinische Klinik 1, Universitätsklinikum Frankfurt – Goethe-Universität
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Part 1 Written informed consent, In- or outpatient at the Department of Respiratory Medicine, University Hospital Frankfurt, Existing diagnosis of one or more of the following: pneumonia, chronic obstructive pulmonary disease, asthma, lung carcinoma, interstitial lung disease, cystic fibrosis Part 2 Written informed consent, Scheduled bronchoscopy with bronchoalveolar lavage
Exclusion criteria
Exclusion criteria: Suspected or confirmed pulmonary infection with a pathogen of risk group 3 or higher (e.g., Mycobacterium tuberculosis) as published by Committee on Biological Agents / German Federal Institute of Occupational Safety and Health, Inability to understand the nature, scope, and possible consequences of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First part of the study: Improving the detection of airway bacteria by ISpro technology. Second part of the study: Demonstrate that throat-/ nose-swabs or sputum samples are a viable alternative to bronchoalveolar lavage for analyzing the airway microbiome by ISpro technology | — |
Countries
Germany
Contacts
Public ContactGernot Rohde
Pneumologie/Allergologie, Medizinische Klinik 1, Universitätsklinikum Frankfurt – Goethe-Universität
Outcome results
None listed